FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, and deals with medication for internal application in form of tablets, in composition of which main active substance is mexidol. Pharmaceutical medication in form of tablet contains mexidol, lactose monohydrate, magnesium stearate and sodium carboxylmethylcellulose. Additionally pharmaceutical medication can contain collidone 30 (polyvinylpyrrolidone). Tablets are mainly covered with coating based on film-producing suspension Opadry II white.
EFFECT: elaboration of novel medication.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT | 2010 |
|
RU2444359C1 |
PHARMACEUTICAL COMPOSITION IN THE FORM OF A COATED TABLET | 2022 |
|
RU2786073C1 |
METHOD FOR PRODUCTION OF ANTIOXIDANT PREPARATION IN FORM OF TABLET | 2020 |
|
RU2749718C1 |
METHOD OF PRODUCING AN ANTIOXIDANT AGENT IN THE FORM OF A TABLET WITH PROLONGED EFFECT | 2019 |
|
RU2712445C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS WITH ENTERIC COATING AND METHOD OF PREPARATION THEREOF | 2015 |
|
RU2668499C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE | 2021 |
|
RU2798106C1 |
DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
PHARMACEUTICAL AGENT | 2009 |
|
RU2410094C1 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
Authors
Dates
2011-09-10—Published
2010-02-12—Filed